Filed with the SEC on · Summarized by InvestorsBot
Kaye Mark, executive vice president and chief financial officer of Elevance Health, sold 10,584 shares in open-market transactions on Oct. 22, 2026, at prices ranging from $434.00 to $447.19 per share. The sales totaled approximately $4,658,357, and Mark owned 19,919 shares afterward.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeElevance Health raises 2026 guidance after third-quarter earnings increase
8-K · October 21, 2026
Elevance reaffirms 2026 earnings and benefit expense ratio guidance
8-K · September 10, 2026
Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit…
8-K · March 10, 2026
Feb 27, 2026: CMS notified Elevance Health ($ELV) of intent to impose intermediate sanctions — suspend…
8-K · March 2, 2026
Elevance Health ($ELV) filed an 8‑K on Feb 26, 2026 furnishing a press release (Exhibit 99.1) and the…
8-K · February 26, 2026
Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net…
8-K · February 26, 2026